Clinical Trial Update: Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the optimal morphine dosing schedule for neonatal abstinence syndrome has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome
• Neonatal Opioid Withdrawal

Snippet

Sponsor: Indiana University | Conditions: Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal | Phase 4 | Status: COMPLETED | Results posted: 2022-09-08